Todd Nelson
Directeur/Membre du Conseil chez TELESIS BIO, INC.
Fortune : 39 494 $ au 31/05/2024
Profil
Todd R.
Nelson is the founder of Tonbo Biotechnologies Corp.
(founded in 2011).
He is currently a Director at LOKOYA Advisors LLC and a Director at Telesis Bio, Inc. (since 2018).
Dr. Nelson has held former positions as President & Chief Executive Officer at MP Biomedicals LLC (2011-2014), Chief Executive Officer & Director at Eurofins DiscoverX Corp., Inc. (2014-2017), and Chief Executive Officer at eBioscience, Inc. (2007-2011).
He has also served as a Director at FluoroPharma, Inc., Eurofins Genomics Blue Heron LLC, and TScan Therapeutics, Inc. Additionally, Dr. Nelson has held positions at Merrill Lynch & Co., Inc., Invitrogen Corp., RBC Capital Markets LLC, and Life Technologies Corp.
He holds an MBA and a doctorate from the University of Minnesota, as well as an MBA from The Curtis L.
Carlson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TELESIS BIO, INC.
0,58% | 01/03/2024 | 9 680 ( 0,58% ) | 39 494 $ | 31/05/2024 |
Postes actifs de Todd Nelson
| Sociétés | Poste | Début |
|---|---|---|
| TELESIS BIO, INC. | Directeur/Membre du Conseil | 01/07/2018 |
LOKOYA Advisors LLC
 LOKOYA Advisors LLC Investment Banks/BrokersFinance LOKOYA Advisors LLC is a private company based in Dover, DE. | Directeur/Membre du Conseil | - |
Anciens postes connus de Todd Nelson
| Sociétés | Poste | Fin |
|---|---|---|
Eurofins DiscoverX Corp., Inc.
 Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Directeur Général | 01/10/2017 |
MP Biomedicals LLC
 MP Biomedicals LLC BiotechnologyHealth Technology MP Biomedicals LLC manufactures and sells biotechnology research products. Its products include adsorbents, antibodies and immunoreagents, apoptosis, biochemicals and reagents, culture media and reagents, kits and assays, lab detergents and sanitizers, labware and instruments, proteins, enzymes, and peptides, radiochemicals, rare and fine chemicals, and research diets. The company was founded by Milan Paninc in 1959 and is headquartered in Santa Ana, CA. | Directeur Général | 01/10/2014 |
eBioscience, Inc.
 eBioscience, Inc. BiotechnologyHealth Technology eBioscience, Inc. manufactures staple research reagents. The company was founded in 1999 and is headquarter in Santa Clara, CA. | Directeur Général | 01/01/2011 |
| TSCAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
RBC Capital Markets LLC
 RBC Capital Markets LLC Investment Banks/BrokersFinance RBC Capital Markets LLC is a full-service brokerage and financial services firm headquartered in New York City. They are a direct subsidiary of RBC USA Holdco Corp. and a wholly-owned indirect subsidiary of Royal Bank of Canada (TSE, NYSE: RY). Founded in 2010, the firm is comprised of 3 major business lines: the Private Client Group, the Fixed-Income Group and the Clearing and Execution Services Group. The Private Client Group serves individual investors, while the Fixed-Income Group provides services to institutions, municipalities and non-profit organizations. The Clearing and Execution Services Group is a provider of clearing and execution services to independent brokers/dealers throughout the US. RBC Capital Markets focuses on the following sectors: communications, media, consumer/retail, diversified industries, energy, financial institutions, forest products, healthcare, infrastructure finance, mining & metals, real estate, social infrastructure, technology and the US municipal markets. | Corporate Officer/Principal | - |
Formation de Todd Nelson
| University of Minnesota | Doctorate Degree |
| The Curtis L. Carlson School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TELESIS BIO, INC. | Commercial Services |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
eBioscience, Inc.
eBioscience, Inc. BiotechnologyHealth Technology eBioscience, Inc. manufactures staple research reagents. The company was founded in 1999 and is headquarter in Santa Clara, CA. | Health Technology |
Eurofins Genomics Blue Heron LLC
 Eurofins Genomics Blue Heron LLC Miscellaneous Commercial ServicesCommercial Services Eurofins Genomics Blue Heron LLC engages in the development of accurate gene synthesis platform for the production of genes and gene variants for use in expression analysis. Its services include GeneMaker technology, vector synthesis & custom cloning, plasmid preparation, and variant library. The company was founded by John Mulligan in 1999 and is headquartered in Bothell, WA. | Commercial Services |
FluoroPharma, Inc.
 FluoroPharma, Inc. Medical SpecialtiesHealth Technology FluoroPharma, Inc. manufactures diagnostic imaging products. It engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company was founded by David R. Elmaleh in 2003 and is headquartered in Boston, MA. | Health Technology |
LOKOYA Advisors LLC
LOKOYA Advisors LLC Investment Banks/BrokersFinance LOKOYA Advisors LLC is a private company based in Dover, DE. | Finance |
Invitrogen Corp.
 Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Electronic Technology |
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Finance |
MP Biomedicals LLC
MP Biomedicals LLC BiotechnologyHealth Technology MP Biomedicals LLC manufactures and sells biotechnology research products. Its products include adsorbents, antibodies and immunoreagents, apoptosis, biochemicals and reagents, culture media and reagents, kits and assays, lab detergents and sanitizers, labware and instruments, proteins, enzymes, and peptides, radiochemicals, rare and fine chemicals, and research diets. The company was founded by Milan Paninc in 1959 and is headquartered in Santa Ana, CA. | Health Technology |
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Health Technology |
Tonbo Biotechnologies Corp.
 Tonbo Biotechnologies Corp. BiotechnologyHealth Technology Tonbo Biotechnologies Corp. provides cell analysis reagents for use in in-vitro cell assays and protocols. It offers antibodies and reagents, recombinant proteins, PCR reagents, and research focus as well as technical support and custom and bulk reagents. The company was founded by Todd R. Nelson and john Miller in 2011 and is headquartered in San Diego, CA. | Health Technology |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance RBC Capital Markets LLC is a full-service brokerage and financial services firm headquartered in New York City. They are a direct subsidiary of RBC USA Holdco Corp. and a wholly-owned indirect subsidiary of Royal Bank of Canada (TSE, NYSE: RY). Founded in 2010, the firm is comprised of 3 major business lines: the Private Client Group, the Fixed-Income Group and the Clearing and Execution Services Group. The Private Client Group serves individual investors, while the Fixed-Income Group provides services to institutions, municipalities and non-profit organizations. The Clearing and Execution Services Group is a provider of clearing and execution services to independent brokers/dealers throughout the US. RBC Capital Markets focuses on the following sectors: communications, media, consumer/retail, diversified industries, energy, financial institutions, forest products, healthcare, infrastructure finance, mining & metals, real estate, social infrastructure, technology and the US municipal markets. | Finance |
